We are live on ! Find out more
AMTX icon

Aemetis

93 hedge funds and large institutions have $238M invested in Aemetis in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more call options, than puts

Call options by funds: $7.66M | Put options by funds: $5.64M

8% more capital invested

Capital invested by funds: $221M → $238M (+$16.9M)

1.54% more ownership

Funds ownership: 54.04%55.58% (+1.5%)

6% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 32

3% less funds holding

Funds holding: 9693 (-3)

10% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 20

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
93
Holders Change
-3
Holders Change %
-3.13%
% of All Funds
1.46%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
18
Increased
30
Reduced
32
Closed
20
Calls
$7.66M
Puts
$5.64M
Net Calls
+$2.02M
Net Calls Change
-$2.13M

AMTX Hedge Fund Activity: Q1 2022 in Review

93 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Aemetis (AMTX) for Q1 2022, worth a combined $238M — up 7.6% from $221M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of AMTX and 18 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 30 added.

The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), adding an estimated $7.9M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $3.68M sold.

  • 93 institutional investors held Aemetis (AMTX) as of Q1 2022, down from 96 in Q4 2021.
  • Funds reported $238M of Aemetis stock for Q1 2022, up 7.6% quarter-over-quarter.
  • 18 funds opened new Aemetis positions in Q1 2022 and 20 closed out, a net change of -2 holders.
  • The largest Aemetis buyer in Q1 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $7.9M added.
  • The largest Aemetis seller in Q1 2022 was Balyasny Asset Management, an estimated $3.68M sold.

Based on aggregated 13F filings for Q1 2022.